fashion -WSS

fashion

author：comprehensive 2025-10-01 14:19:41 - browse：543

Fiona Marshall, president of the Novartis research hub in Cambridge, Mass., speaks Thursday during the STAT Future Summit. STAT

Swiss drugmaker Novartis’ research and development hub has a new name — and a new guiding strategy.

The hub, which is headquartered in Cambridge, Mass., and for years has been known as Novartis Institutes for BioMedical Research, or NIBR, will soon simply be known as Novartis Biomedical Research.

But that’s not the only thing that’s changing, Fiona Marshall, the hub’s president, told a virtual audience Thursday during the 2023 STAT Future Summit. The new name reflects a larger shift by the pharma giant to retool its research strategy — from one driven by the pure pursuit of scientific discovery to a tighter focus on projects likely to yield commercially successful drugs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： India sets sights on home

explore

WSS

Medical experts are missing from AI regulatory conversations

There's an unseen cost to disruptive road

Resistance to cancer drugs: A new genetic explanation

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

Future doctors need a strong humanities education

Printout prescription drug information shouldn’t go digital

leisure time

fashion

focus

Heart attack and stroke risk calculators need revising

Maisha Meds is a PBM, but don't call it that

The high cost of giving birth even with insurance

Seattle police shoot person suspected in downtown stabbing

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Dana Farber says 6 studies to be retracted and 31 corrected

FDA approval of Sarepta Duchenne genetic therapy gives me hope

FDA endorses new sterilization method for medical devices

Medical leaders decry Supreme Court decision on affirmative action

Lindsay Lohan welcomes 1st child with husband Bader Shammas

hotspot

Pumping milk in bathrooms at health conferences is common

To bolster infectious disease surveillance, genomics powerhouses team up

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

Update the Apgar Score to remove skin color

India sets sights on home

Prior authorization reform is both possible and imperative

explore

explore

explore

knowledge